A Prospective Multi-Center Randomized Open-Label Study To Evaluate The Efficacy and Safety of PMX Cartridge in addition to Standard Medical Care for Patients with Endotoxemic Septic Shock: TIGRIS TRIAL
Primary Objective
The primary objective is to compare the safety and efficacy of the PMX cartridge (Toraymyxin) based on mortality at 28 days in patients with septic shock and endotoxemia who are treated with standard medical care plus the use of the PMX cartridge, versus patients who receive standard medical care alone.
Details
Age
Adult
Type of Study
Device Feasibility
Scope
National
Locations
Memorial Hospital Central
Principal Investigator
Ronald Rains
Study ID
Protocol Number: 19-6070
More information available at ClinicalTrials.gov: NCT03901807
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers